TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive In Brief: Congress Working On Interim Financing Measure to Fund Agencies, Including NCI, Through Election September 26, 1980